Literature DB >> 18387780

Genes regulating the serotonin metabolic pathway in the brain stem and their role in the etiopathogenesis of the sudden infant death syndrome.

Francesco Nonnis Marzano1, Milena Maldini, Laura Filonzi, Anna Maria Lavezzi, Stefano Parmigiani, Cinzia Magnani, Giulio Bevilacqua, Luigi Matturri.   

Abstract

Genotypes and allelic frequencies of TPH2, 5-HTTLPR, the 5-HTT (SLC6A4) intron 2 variable-number tandem repeat (VNTR) region, and the MAOA VNTR region were determined in brain-stem samples of 20 "genuine" SIDS cases and compared with results obtained from 150 healthy controls. The SNP G1463A responsible for 80% functionality loss of TPH2 (tryptophan hydroxylase 2) was not detected, neither in SIDS infants nor in the controls. In contrast, a strict relation was found between the 5-HTTLPR genotype and its allelic frequencies with SIDS cases. The L/L genotype and the long allele (L) of the promoter region of the serotonin transporter were significantly associated (likelihood ratio (LR) test, p<0.001) with the syndrome (L/L, 60% SIDS vs 14% controls; L, 80% SIDS vs 42.6% controls). Polymorphisms of the intron 2 VNTR of the same gene showed a trend for significant differences between genotypes 10/10 and 12/12 (LR test, p=0.068), with the L-12 haplotype being almost twofold in SIDS (44.5%) with respect to controls (23.4%). Differences were even higher considering the genotype combination L/L-12/12 (20% SIDS vs 2.6%), and variations among categories were statistically highly significant (p<0.001). Although additional differences were observed in the frequency of the MAOA (monoamine oxidase A) VNTR genotype 3R/3R between SIDS and controls (respectively 15% vs 26%), the results were not supported by statistical significance. Molecular polymorphisms are discussed considering their functional role in regulating serotonin synthesis (TPH2), neuronal reuptake (5-HTTLPR and 5-HTT intron 2), and catabolism (MAOA) in the nervous system of Italian SIDS infants. Comparisons are made with previous data obtained in different ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387780     DOI: 10.1016/j.ygeno.2008.01.010

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

Review 1.  Gene variants predisposing to SIDS: current knowledge.

Authors:  Siri H Opdal; Torleiv O Rognum
Journal:  Forensic Sci Med Pathol       Date:  2010-07-11       Impact factor: 2.007

2.  PHOX2B polyalanine repeat length is associated with sudden infant death syndrome and unclassified sudden infant death in the Dutch population.

Authors:  Germaine Liebrechts-Akkerman; Fan Liu; Oscar Lao; Ariadne H A G Ooms; Kate van Duijn; Mark Vermeulen; Vincent W Jaddoe; Albert Hofman; Adèle C Engelberts; Manfred Kayser
Journal:  Int J Legal Med       Date:  2014-01-18       Impact factor: 2.686

Review 3.  Serotonin gene variants are unlikely to play a significant role in the pathogenesis of the sudden infant death syndrome.

Authors:  David S Paterson
Journal:  Respir Physiol Neurobiol       Date:  2013-07-10       Impact factor: 1.931

4.  Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis.

Authors:  Laura Filonzi; Cinzia Magnani; Anna Maria Lavezzi; Guido Rindi; Stefano Parmigiani; Giulio Bevilacqua; Luigi Matturri; Francesco Nonnis Marzano
Journal:  Neurogenetics       Date:  2008-09-23       Impact factor: 2.660

Review 5.  How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.

Authors:  Dennis L Murphy; Meredith A Fox; Kiara R Timpano; Pablo R Moya; Renee Ren-Patterson; Anne M Andrews; Andrew Holmes; Klaus-Peter Lesch; Jens R Wendland
Journal:  Neuropharmacology       Date:  2008-09-11       Impact factor: 5.250

6.  Questionable association between a monoamine oxidase A promoter polymorphism and sudden infant death syndrome.

Authors:  Michael Klintschar; Christian Heimbold
Journal:  Neurogenetics       Date:  2010-04-01       Impact factor: 2.660

7.  Abolishment of serotonergic neurotransmission to cardiac vagal neurons during and after hypoxia and hypercapnia with prenatal nicotine exposure.

Authors:  H W Kamendi; Q Cheng; O Dergacheva; C Gorini; H S Jameson; X Wang; J M McIntosh; D Mendelowitz
Journal:  J Neurophysiol       Date:  2008-12-17       Impact factor: 2.714

8.  The potential role of myostatin and neurotransmission genes in elite sport performances.

Authors:  L Filonzi; N Franchini; M Vaghi; S Chiesa; F Nonnis Marzano
Journal:  J Biosci       Date:  2015-09       Impact factor: 1.826

Review 9.  Medullary serotonin defects and respiratory dysfunction in sudden infant death syndrome.

Authors:  David S Paterson; Gerard Hilaire; Debra E Weese-Mayer
Journal:  Respir Physiol Neurobiol       Date:  2009-05-27       Impact factor: 1.931

10.  High serum serotonin in sudden infant death syndrome.

Authors:  Robin L Haynes; Andrew L Frelinger; Emma K Giles; Richard D Goldstein; Hoa Tran; Harry P Kozakewich; Elisabeth A Haas; Anja J Gerrits; Othon J Mena; Felicia L Trachtenberg; David S Paterson; Gerard T Berry; Khosrow Adeli; Hannah C Kinney; Alan D Michelson
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.